Platelet-derived miRNAs as determinants of the antiplatelet response in clopidogrel-treated patients with ACS

Thromb Res. 2020 Feb:186:71-74. doi: 10.1016/j.thromres.2019.12.016. Epub 2019 Dec 24.

Authors

Jun Liu¹, Liuan Qin¹, Ziqian Wang¹, Li Peng¹, Jia Liu¹, Xuyun Wang¹, Rina Du¹, Yuting Zou¹, Yangxun Wu¹, Tong Yin²

Affiliations

¹ Department of Cardiology, First Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China.
² Department of Cardiology, First Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China. Electronic address: yintong2000@yahoo.com.

PMID: 31891827
DOI: 10.1016/j.thromres.2019.12.016

No abstract available

Keywords: Acute coronary syndrome; Clopidogrel; Platelet reactivity; microRNAs.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Acute Coronary Syndrome* / drug therapy
Blood Platelets
Clopidogrel / therapeutic use
Humans
MicroRNAs* / genetics
Percutaneous Coronary Intervention*
Platelet Aggregation Inhibitors / therapeutic use
Prasugrel Hydrochloride
Treatment Outcome

Substances

MicroRNAs
Platelet Aggregation Inhibitors
Clopidogrel
Prasugrel Hydrochloride